|
HS Code |
889250 |
| Generic Name | Enalapril Maleate |
| Brand Names | Vasotec, Epaned |
| Drug Class | Angiotensin-Converting Enzyme (ACE) Inhibitor |
| Chemical Formula | C20H28N2O5·C4H4O4 |
| Molecular Weight | 492.52 g/mol |
| Indication | Hypertension, heart failure, asymptomatic left ventricular dysfunction |
| Dosage Form | Tablet, oral solution |
| Route Of Administration | Oral |
| Prescription Status | Prescription-only |
| Mechanism Of Action | Inhibits ACE, reducing angiotensin II production and lowering blood pressure |
| Common Side Effects | Cough, dizziness, fatigue, headache, hyperkalemia |
| Contraindications | Pregnancy, history of angioedema related to previous ACE inhibitor therapy |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F) |
As an accredited Enalapril Maleate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Enalapril Maleate, 100g: Supplied in a tightly sealed, amber glass bottle with tamper-evident cap and clear hazard labeling. |
| Shipping | Enalapril Maleate is shipped in tightly sealed, clearly labeled containers, protected from moisture and light. It is transported under controlled temperature conditions to maintain stability and integrity. Proper documentation accompanies each shipment, and handling complies with safety regulations for pharmaceuticals. Shipping is tracked to ensure timely and secure delivery. |
| Storage | Enalapril Maleate should be stored in a tightly closed container, protected from moisture and light. Keep it at a controlled room temperature between 20°C and 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (59°F to 86°F). Store in a dry area, away from incompatible substances, and out of reach of children and pets. |
|
Purity 99%: Enalapril Maleate with purity 99% is used in pharmaceutical tablet formulations, where it ensures optimal bioavailability and therapeutic efficacy in hypertension management. Melting Point 143°C: Enalapril Maleate with melting point 143°C is used in controlled-release drug delivery systems, where it allows precise formulation processing and stable product performance. Particle Size <50 µm: Enalapril Maleate with particle size <50 µm is used in oral suspension preparations, where it promotes uniform dispersion and improved dissolution rates. Stability Temperature up to 40°C: Enalapril Maleate with stability temperature up to 40°C is used in long-term storage of antihypertensive medications, where it maintains chemical integrity and extends shelf life. Molecular Weight 492.53 g/mol: Enalapril Maleate with molecular weight 492.53 g/mol is used in dose calibration for clinical trials, where it provides accurate compound measurement and consistent pharmacokinetic outcomes. Water Solubility 12 mg/mL: Enalapril Maleate with water solubility of 12 mg/mL is used in liquid oral drug formulations, where it enables rapid and effective drug absorption. Residual Solvents <0.1%: Enalapril Maleate with residual solvents below 0.1% is used in pediatric medicine production, where it reduces toxicity risk and complies with safety standards. |
Competitive Enalapril Maleate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
For many years, Enalapril Maleate has remained on the production line because it addresses hypertension and heart failure needs every single working day. At our plant, we learned early on that the smallest shift in humidity or a batch’s particle size can change its processing time. From the very first run, we saw every lot required close attention. Our experience comes not from reading spec sheets but from handling the work of scale-up, routine maintenance, and daily troubleshooting.
We run Enalapril Maleate under a strict set of protocols. Our USP grade product comes as a white to off-white crystalline powder, with solubility in both water and ethanol. Hygroscopic tendencies demand a dry workroom and well-sealed packaging. Each batch is tested for identity, heavy metals, water content, assay, and organic impurities—no batch ships without full confirmation of compliance. Our QC staff inputs data directly from spectrometers, HPLC, and Karl Fischer titrations. Experience shows a wider particle size distribution pushes the blend out of range, so we carefully control milling and sifting.
With Enalapril Maleate, achieving uniformity, purity, and handling safety counts for more than a certificate on paper. Insufficient drying, for example, can affect assay results. Too much moisture clumps the powder, slowing filling and compression in downstream tablet or capsule runs. Our people tweaked drying temperatures over time until we hit repeatable water content (usually not above 5%). Staff learned to catch inconsistent batches from sight or feel alone, before tests even begin.
A plant manager notices the impact of one off-grade lot. Laboratories and finished-dosage manufacturers count on clear labels and reliable assay, as tiny shifts can force a line shutdown. No spec sheet can substitute for a reputation honed across hundreds of batches; those who run the filling line remember who supplied yesterday’s reliable product. We engineer processes to deliver consistency—not just a minimum result, but the kind of reliability that says, ‘your manufacturing task just got easier.’
Our Enalapril Maleate stands apart in the market because we never cut corners for price. Finished product line operators often face clogged feeder hoppers or unexpected fines contaminating the air. If your own process relies on set blending times for tablets, or low-dust filling rooms, you can count on our powder to meet and exceed those requirements. By sticking with robust, proven purification and drying techniques, we prevent downstream production tickets from piling up.
Customers raise concerns about batch-to-batch differences encountered with lower-grade imports. We hear these stories from solid dosage teams who handle a dozen antihypertensive APIs monthly. Tablets must fall within a narrow weight and content uniformity range; too much variation causes batch rejection and expensive downtime. Drawing on our years of handling dozens of APIs, we invest extra effort into granulation and repeated in-process controls, not because compliance demands it, but because we have seen what happens when shortcuts are taken. If you’ve ever watched a team clean up caked bins after a powder bridging incident, you’ll value the focus we put on powder flow and moisture.
We make Enalapril Maleate for oral solid dose production, both tablets and capsules. In the compounding pharmacy world, you’ll find it meeting the same strict standards as bulk for formulators blending antihypertensive mixtures. We’ve worked through pelleting, micro-encapsulation trials, and direct compression studies in our own application labs. Maybe you’re running continuous mixer lines or small batch planetary blenders—we have supplied both setups, each with practical, problem-solving insight.
Size matters in commercial production. Some customers want small 10-kg packs to feed capsule lines, others need 100-kg drums for round-the-clock tablet runs, and all of them ask us for not just supply, but support. Our logistics are shaped by a fundamental fact: downtime wastes more than money; it erodes team morale and endangers schedules for everyone from line workers to contract-manufacturer partners. We take responsibility for ensuring every drum that leaves the warehouse gives teams the best start on an undisturbed, productive run.
Customers press for answers about organic impurity limits, solvent residuals, and every imaginable specification. Questions about degradation products are routine. We’ve been through dozens of regulatory inspections and readings, both from international clients and home authorities. We consistently demonstrate that our process avoids cross-contamination and shortcut synthesis. Our documentation shows traceable lots, right down to the solvent runs. Each certificate we ship has met not just pharmacopeial standards, but batch-specific scrutiny, with full transparency.
Environmental residues, such as organic solvents, represent one of the persistent struggles in large-scale API manufacture. Our investment in vacuum drying, closed transfer lines, and in-process analytical checks does not just keep inspectors happy; it means clients know what they receive will not spike their next batch run. Auditors from multiple countries have witnessed the care we take, and repeat business comes from those who have seen and touched the product themselves rather than trusting a digital image or third party.
Comparing Enalapril Maleate across suppliers shows where shortcuts can spoil a day’s work. Bulk density, for example, shapes both storage and ease of use. Overly light batches fluff up and cause dusting, while over-compressed batches jam tablet presses. The way our production technicians tweak mixer speed or drying duration comes from years of hands-on feedback, not distant theorizing.
A genuine manufacturer understands that the utility of the API starts long before the first pill is produced and ends months later, when batch records are reviewed for efficiency and compliance. We never forget that our powder passes through a chain of care—from warehouse, to blending, granulating, compressing, and finally release testing in the finished product. Upstream mistakes haunt the process at every stage, so our process build on direct experience, constant operator training, and a shared sense that no batch is secondary.
Production shifts with market demands and regulatory updates. Recent years have seen tightening impurity thresholds, and we have adapted by expanding our analytical equipment. Our engineers and chemists meet every quarter to discuss real findings—no theoretical bulletins, only actual outcomes. If a new standard emerges in the EU or North America, we are ready to run side-by-side tests, resolve any discrepancies, and update our controls. Our line workers, having often started at entry level, speak frankly about how product changes affect their work. Their insight keeps our management grounded.
Pharmaceutical partners benefit when they can audit, visit, and witness our commitment to each stage—from raw material inspection to finished drum packaging. Real dialogue with buyers and technical teams has shaped our upgrade schedule, hygiene controls, and even documentation. Beyond regulatory “checklist” adherence, we prize the honest conversations and detailed feedback loops that keep us improving batch after batch.
We learned the hard way that storage matters just as much as synthesis. Hygroscopic Enalapril Maleate quickly absorbs water if left open to air, so our operators use nitrogen flushing and tight-sealing inner liners. Training never stops at the production step; warehouse and shipping staff focus on quick turnover, shaded storage, and careful handling to avoid quality loss from ambient humidity or sunlight.
Experience shows shipping a poorly sealed drum can lead to a stubborn, time-eating sticky mass. We mark each drum with reminders about best conditions for extended holding. For local customers, we share extra tips: use smaller open packs, keep temperature steady, and watch for visible clumps when opening. Every detail speaks to knowledge built up over years, making sure that from our floor to yours, nothing is left to chance.
Plenty of products come with glossy spec sheets or generic claims. The real differences appear as soon as your own people put the API through their paces. Stringent monitoring of particle distribution, careful drying, and absence of caking mean our product answers problems that others often cause. As manufacturers, we are regularly asked about product comparison. We share real data—direct mill output, as well as post-packaging testing. No claim goes unsupported; we show samples and send technical staff to talk through results, not just sales representatives reading scripts.
Quality separates good Enalapril Maleate from mediocre substitutes. Over the years, clients switching from cheaper alternatives report dramatic falls in batch rejections and less time spent clearing blockages or re-blending failed mixes. By building in extra steps—extended drying times, double sieving, rigorous lot traceability—we reduce not only headline impurity numbers but also the subtle defects that cause headaches during FDA or EU compliance reviews.
Downstream users share reports with us, sometimes positive, sometimes looking for help. Tablet producers prefer powders that flow without bridging or caking, and capsule fillers want uniform fill weights. Common pain points include clumping from heat exposure or loss in assay with faulty storage. We combine their field reports with our own QA findings to make ongoing improvements. When we see the same issues repeated, we invite clients to discuss process tweaks and run joint pilot batches, avoiding blame and instead building better product together.
Some clients introduce Enalapril Maleate late in the formulation, as a final API to avoid interaction or degradation. Our low-impurity version often solves compatibility or shelf-life issues in complex multi-drug tablets. For liquid form manufacturers, solubility and absence of visible particulates remain critical. We document every filtration and dissolution result, learning from each to guide production for the next round.
Every production run acts as another test of our methods. Yearly reviews, unexpected audit requests, and spot-checks keep every technician alert. If a batch fails an assay or shows deviation from particle norms, our teams sit down immediately to investigate. There’s no substitute for knowing your own process inside and out. This kind of diligence doesn’t come from external pressure but from inside, from knowing the final medication helps patients control blood pressure and heart conditions safely. Real quality assurance comes from daily engagement, not quarterly summary meetings.
Supplier relationships turn into long-term partnerships only when both sides recognize value in the details: stable supply, transparent communication, no surprise deviations. We’ve maintained clients for over a decade because we respond to unexpected hitches, support validation exercises, and help write process improvements jointly. The best feedback comes directly from production teams, lineside, reporting on real-life outcomes that end up shaping our own internal procedures for the better.
A manufacturer’s pride stands behind every drum of Enalapril Maleate that leaves the plant. This reputation grows over time, as each operator and manager knows that getting it right saves effort at every stage. Behind every certificate of analysis is not just compliance with a checklist, but the result of attention, commitment, and thousands of hours logged by skilled teams. We value open dialogue and direct feedback, striving to build on both successes and tough lessons learned through hands-on experience in real-world pharmaceutical environments.
Every day, line workers and laboratory analysts rely on Enalapril Maleate that won’t let them down. Our legacy isn’t a marketing slogan, but years of standing together with customers, fixing real challenges, and delivering more than just a chemical: a product shaped by knowledge, skill, and a shared commitment to pharmaceutical progress.